Clinuvel Pharmaceuticals Says JPMorgan Increases Stake

MT Newswires Live04-13

Clinuvel Pharmaceuticals (ASX:CUV) said JPMorgan Chase & Co. and its affiliates have increased their stake in the company on April 8 to 7.02% or 3.5 million shares from 5.57% or 2.8 million shares, according to a Monday Australian bourse filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment